Actively Recruiting
Evaluation of AI-Enhanced Symptom Summarization in Weekly Radiotherapy Consultations: A Comparative Study
Led by jaide · Updated on 2024-10-10
200
Participants Needed
1
Research Sites
6 weeks
Total Duration
On this page
Sponsors
J
jaide
Lead Sponsor
N
National Cancer Institute, Brazil
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the use of artificial intelligence (AI) and large language models to improve the efficiency and accuracy of weekly treatment consultations for patients undergoing radiotherapy in the pelvic area. The study aims to compare AI-generated symptom summaries with traditional doctor-led reviews to see if AI can match accuracy while saving time. This is a comparative clinical trial focusing on patients receiving pelvic radiotherapy, excluding those with prior pelvic reirradiation or surgery. Participants receive both standard weekly consultations with a physician and separate consultations where AI-assisted symptom summaries are generated using the OpenAI GPT-4 API. These AI summaries are compared with traditional doctor summaries by blinded specialist doctors using a validated questionnaire called the Physician Documentation Quality Instrument-9 (PDQI-9). The study also gathers satisfaction ratings from both patients and physicians regarding clarity, accuracy, and overall experience. During the study, time needed to complete each type of consultation is tracked to assess efficiency. Patients undergo symptom questionnaires under medical supervision during their AI-assisted visits. Researchers evaluate documentation quality, time efficiency, physician satisfaction, and patient satisfaction over a two-month period. The trial began in July 2024 and is expected to complete by December 2024.
CONDITIONS
Brief Title
AI as an Aid for Weekly Symptom Intake in Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients undergoing radiotherapy in the pelvic region
- Age 18 years or older
You will not qualify if you...
- Cases of pelvic reirradiation
- Patients who have had pelvic surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 months
Participants undergo weekly radiotherapy consultations during which symptom intake is assessed both by standard physician methods and AI-assisted tools to compare documentation accuracy and time efficiency.
Weekly visits for up to 8 weeks
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA
Rio de Janeiro, Brazil
Actively Recruiting
Research Team
R
Rachele Grazziotin, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here